...
首页> 外文期刊>Journal of diabetes research. >miR-210 in Exosomes Derived from Macrophages under High Glucose Promotes Mouse Diabetic Obesity Pathogenesis by Suppressing NDUFA4 Expression
【24h】

miR-210 in Exosomes Derived from Macrophages under High Glucose Promotes Mouse Diabetic Obesity Pathogenesis by Suppressing NDUFA4 Expression

机译:在高葡萄糖下衍生自巨噬细胞的外泌体中的miR-210通过抑制Ndufa4表达来促进小鼠糖尿病肥胖性发病机制

获取原文

摘要

Objective. Type 2 diabetes mellitus (T2DM) is featured by insulin resistance and lipid metabolism dysregulation. A large number of miRNAs were identified in exosomes derived from adipose tissue macrophages associated with T2DM pathogenesis, but its pathogenic roles remain unknown. This study is aimed at investigating the function of miR-210 in diabetic obesity. Methods. Exosomes from mouse macrophage RAW264.7 cells were characterized by electron microscopy, combined with biomarker expression by western blot. Expression of miR-210 was determined by quantitative RT-PCR. Glucose uptake was measured by a fluorometric method, and the mitochondrial respiratory chain activity was evaluated by ELISA. The target gene of miR-210 was validated by dual-luciferase reporter and pull-down assays. A mouse obese diabetic model was established by a high-fat diet and streptozocin treatment. Results. miR-210 was highly expressed in exosomes derived from high glucose-induced macrophage RAW264.7 cells. Macrophage-derived exosomes impaired glucose uptake and mitochondrial CIV complex activity and suppressed NADH dehydrogenase ubiquinone 1 alpha subcomplex 4 (NDUFA4) expression in 3T3-L1 adipocytes. miR-210 directly bind with mRNA sequences of NDUFA4 gene. Inhibition of miR-210 mitigated the effects of macrophage-derived exosomes on the glucose uptake and complex IV (CIV) activity in 3T3-L1 adipocytes, and NDUFA4 overexpression offset the inhibition of glucose uptake and CIV activity by macrophage-derived exosomes. Furthermore, mice with miR-210 knockout showed greatly repressed diabetic obesity development. Conclusion. miR-210 derived from adipose tissue macrophages promotes mouse obese diabetes pathogenesis by regulating glucose uptake and mitochondrial CIV activity through targeting NDUFA4 gene expression.
机译:客观的。 2型糖尿病(T2DM)由胰岛素抵抗和脂质代谢诱导剂进行特征。在衍生自与T2DM发病机制相关的脂肪组织巨噬细胞的外泌体中鉴定了大量miRNA,但其致病作用仍然未知。本研究旨在研究MIR-210在糖尿病肥胖症中的功能。方法。通过电子显微镜表征来自小鼠巨噬细胞Raw264.7细胞的外泌体,用Western印迹结合生物标志物表达。 MiR-210的表达通过定量RT-PCR测定。通过荧光法测量葡萄糖摄取,通过ELISA评估线粒体呼吸链活性。用双荧光素酶报告和下拉测定验证miR-210的靶基因。通过高脂饮食和链脲酶治疗建立了小鼠肥胖糖尿病模型。结果。 miR-210在源自高葡萄糖诱导的巨噬细胞Raw264.7细胞中源于外泌体表达。巨噬细胞衍生的外泌体损伤葡萄糖摄取和线粒体公心的络合物活性和抑制NADH脱氢酶泛醌1α,3T3-L1脂肪细胞中的表达1α亚偶联4(NDUFA4)表达。 miR-210与Ndufa4基因的mRNA序列直接染色。 MiR-210的抑制减轻了巨噬细胞衍生的外来体对3T3-L1脂肪细胞中的葡萄糖摄取和复合IV(CIV)活性的影响,并且Ndufa4过表达偏移巨噬细胞衍生的外泌体抑制葡萄糖摄取和文​​明活性。此外,MIR-210敲除的小鼠显示出大大压抑的糖尿病肥胖症发展。结论。衍生自脂肪组织巨噬细胞的miR-210通过靶向Ndufa4基因表达来调节葡萄糖摄取和线粒体方案活性来促进小鼠肥胖糖尿病发病机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号